Search for: "MAXIM PHARMACEUTICALS, INC." Results 61 - 80 of 147
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Aug 2009, 4:07 am
Janssen Pharmaceutical, Inc., ___ A.2d ___, 2009 WL 1857395 (Pa. [read post]
4 May 2011, 7:36 am by Tron Emptage
His 20-year plus experience in pharmaceutical and managed care defines him as a key player in moving the company forward in the arena of national pharmaceutical managed care. [read post]
14 Dec 2021, 2:00 pm by Kevin LaCroix
(Note: in July 2018 – almost three years after the shareholder class actions commenced – the company changed its name to Bausch Health Companies, Inc.) [read post]
8 Jan 2024, 11:59 am by luiza
  To try to maximize the company’s efficiency, profitability, and value, the PE firm often seeks to slash costs, including the company’s workforce. [read post]
24 Apr 2017, 11:12 am by John Duffy
Subsection (l) provides a process by which the applicant for a biosimilar license (i.e., the generic pharmaceutical company) can exchange information about patents with the company that first obtained FDA approval to market the original biologic drug (i.e., the research pharmaceutical company). [read post]
2 Aug 2008, 12:54 am
– Technological Innovation and Intellectual Property), IP and start-ups: (Technological Innovation and Intellectual Property), Innovators: Make sure your company owns the fruits of your open innovation projects: (IP Asset Maximizer Blog), It’s all about the numbers: SuperCrunchers of patent data will gain competitive advantage: (IP Asset Maximizer Blog)   Events 4-9 August: Dept Science & Technology indigenous knowledge systems expo and workshop… [read post]
20 Aug 2019, 6:30 am by Rebecca Shafer, J.D.
      Author Rebecca Shafer, JD, President of Amaxx Risk Solutions, Inc. is a national expert in the field of workers compensation. [read post]
4 Aug 2020, 6:30 am by Rebecca Shafer, J.D.
  Author Rebecca Shafer, JD, President of Amaxx Risk Solutions, Inc. is a national expert in the field of workers compensation. [read post]
26 Apr 2012, 7:48 am
As a pharmaceutical liability attorney, I look forward to more precedent on the issue from the Ninth and its sister circuits. [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]